VaccinesNews.net

Vaccines Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19) lasts longer than 6 months is unclear. A retrospective cohort study was conducted using Swedish nationwide registries. The ...


The U.S. Food and Drug Administration ( FDA ) has authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. T ...


Two-dose regimens of the Moderna and Pfizer-BioNTech mRNA vaccines provided a high level of protection against COVID-19 hospitalizations in a real-world evaluation at 21 U.S. hospitals during March–Au ...


Establishing the rate of post-vaccination cardiac myocarditis in the 12-15 and 16-17-year-old population in the context of their COVID-19 hospitalization risk is critical for developing a vaccination ...


The U.S. Food and Drug Administration ( FDA ) has approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty, for th ...


The JCVI ( Joint Committee on Vaccination and Immunisation ) has reviewed the evidence on vaccinating children aged 12 to 15 who do not have underlying health conditions that put them at increased ris ...


The U.S. Food and Drug Administration ( FDA ) has approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty, for th ...


At the time of this report, over 127,892 people across the UK have died within 28 days of a positive test for coronavirus ( COVID-19 ). All vaccines and medicines have some side effects. These side ...


Since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination ( Pfizer-BioNTech and Moderna ), particularly in adolescents a ...


EMA’s human medicines committee ( CHMP ) has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty ( Pfizer / BioNTech ) to include use in children aged 12 to 15. The va ...


The FDA ( U.S. Food and Drug Administration ) has expanded the emergency use authorization ( EUA ) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 ( COVID-19 ) ...


EMA’s safety committee ( PRAC ) has concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen. PRAC has also ...


EMA’s safety committee, PRAC, has concluded its preliminary review of a signal of blood clots in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting of 18 March 2021. ...


The FDA ( U.S. Food and Drug Administration ) has issued an emergency use authorization ( EUA ) for the third vaccine for the prevention of coronavirus disease 2019 ( COVID-19 ) caused by severe acute ...


EMA ( European Medicines Agency ) has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 ( COVID-19 ) in people from 18 yea ...